Does a pharmacoinvasive strategy combining thrombolysis and liberal PCI yield comparable survival rates to primary PCI in patients with STEMI?
A pharmacoinvasive strategy combining thrombolysis with liberal PCI provides comparable early and 1-year survival to primary PCI for STEMI patients treated early.
When used early after the onset of symptoms, a pharmacoinvasive strategy that combines thrombolysis with a liberal use of PCI yields early and 1-year survival rates that are comparable to those of PPCI.
Danchin et al. (Tue,) studied this question.